Transcript Document

Herbal drugs/ Pharmaceuticals –
Problems and Prognosis
Dr. P. Pushpangadan
Director, National Botanical Research Institute
Lucknow, India
5 trillion $
2020
62 billion $
2005
Growing popularity
Business standard, 2005
ccessible
ffordable
ssured safety
About 70% Indian population (60-70
crore) depends on alternative system
of medicine.
WHO
Herbal drugs are
cheaper than generic
drugs !!??
Herbal drugs
have been
used in India
for more than
4000 years.
Allopathy or Modern Medicine
 Glamorized discipline
 Pursued by most (influenced and so called
‘Literate’) in India and, in western countries
 Backed by technological advances investigations
 Based on sound scientific reasoning –
experimental evidence; not anecdotal
 Thus, Modern Medicine is an evidencebased, techno-savvy science that seems to
provide ultimate care to sick patients
Allopathy or Modern Medicine
But????
 The treatment is often symptomatic, costly,
out of reach of most in developing countries
 Except for infective pathologies, we do not
have much to offer except palliation
 Treatment of Chronic Lifestyle Disorders like
neurodegenerative disorders is often very
disappointing and limited by adverse events
 It treats the Disease (symptomatic) and not
the patient ‘as a whole’ (Holistic approach)
Therapeutic Objective
 The ultimate goal of every physician is to
“CURE” the disease.
 Has Allopathy achieved this goal for all
ailments? No;
Except for infective pathologies, we do not
achieve CURE
 Most often the treatment is Symptomatic and
Palliative.
Effective & Safe Medicine
Drug Discovery – problems
 It is notoriously inefficient
 One in a hundred thousand or more compounds will
enter the market as a drug
 Pharma majors have NO interest in higher plants
extracts for screening for biological activity
 In NAPRALERT ethnomedical reports for 14,300
species (5.2% of all plant species) are there;


But 58% of these species have never been examined
biologically or chemically
Of these 74% are used in a manner which parallels
their ethnomedical use
Golden triangle
Traditional medicine
Modern medicine
Modern science
Thus making cheaper affordable and safe medicine
Mashelkar 2005
Examples of some important plant derived drugs
Compound
Plant Species
Acetyl digoxin
Digitalis lanata
Ajmalicine
Catharanthus roseus, Rauwolfia sp.
Ajmmaline
Rauvolfia serpentina
Andrographolide
Andrographis paniculata
Artemissine
Artemisia annua
Asiaticoside
Centella asiatica
Berberine
Berberis spp.
Caffeine
Camellia sinensis
Caffeine
Camellia sinensis
Cocaine
Erythroxylum cocoa
Codeine
Papaver spp.
Codiene
Papaver somniferum
Colchicine
Colchicum autumnale, Gloriosa superba
Curcumin
Curcuma longa
Digitoxin, Digoxin, Digitoxigenin
Digitalis spp.
Emetine
Cephaelis ipecacuanha
Ephedrine
Ephedra gerardiana
Ergometrine, Ergotamine, Ergotoxin
Claviceps purpurea on Rye plants
Glycyrrhizin, Glycyrrhizinic acid
Glycyrrhiza glabra
Hesperidin
Citrus spp. Mentha spp.
Contd..
Examples of some important plant derived drugs (Contd..)
Hyoscine
Duboisia spp.
Hyoscyamine
Datura spp, Hyscyamus spp.
L-Dopa
Mucuna pruriens
Menthol
Mentha spp.
Morphine
Papaver spp.
Papain
Carica papaya
Podophyliotoxin
Podophyllum emodi
Quinine, Quinidine
Cinchona spp.
Reserpine & Deserpidine
Rauvolfia serpentina,
Rutin
Eucalyptus spp, Fagopyrum spp, Sophora japonica
Scopolamin
Datura sp.
Sennosides A&B
Cassia angustifolia, C. acutifolia
Silymarin
Silybum marianum
Strychnine
Strychnos nux-vomica
Taxol
Taxus baccata
Thymol
Vinblastine, Vincristine
Xanthotoxin
Chemical Intermediates
Citral
Diosgenin
Phytosterols (Stigmasterol & Sitosterol)
Thymus vulgaris
Catharanthus roseus
Ammi majus, Heracleum candicans
Solasodine
Hypercin, Hyperforin
Solanum
Hypericum perforatum
Lemon grass
Dioscorea spp. Costus spp.
Soya & Calabar Beans
Traditional medicine
Historical background
 Earliest recorded use of a medicinal plant has
been mentioned in ‘Rigveda’
 one mentioned in the modern texts is that of the
herb called “Ma huang” a species of Ephedra
used medicinally in China for over 5000 years
 Cinchona was used by local south American
tribes long before before the isolation of quinine
for treating malaria
 Source of aspirin (Salix officinalis) was used as
pain killer for long time before being identified
Traditional medicines
 Middle of 19th century, 80% of all medicines
were herbal
 Even today 25% of drugs are derived from
plant source
 Most of these drugs came from traditional
lead, folk knowledge etc.
 Some of these still could not substituted
despite the enormous advancement in
synthetic chemistry eg. Reserpine, taxol,
vincristine etc.
Revival of herbal medicine
 widespread belief that ‘green’ medicine is healthier




than synthetic products
leading to rapid spurt of demand for health products
like herbal tea, ginseng and such products of
traditional medicine
So rapid – sale of herbal products are staggering 100
billion dollars a year.
After India and China, even the western world has
started working on herbals
NIH has set up CAM center and working on St.
John’s wort and Gingko biloba
Drug development based on traditional leads
Survey of traditional remedies
Choice of plant
Traditional formulation
Related
species
Identification,
authentication
Collection
Extraction
Clinical
trial
Biological
screening
Effective
Active
1. Analytical
standard
2. Safety
3. Modernise
Technology
4. New Dosage
Forms
Pharmacokinetics/Pharmacodynamics
Pilot Plant Production
Bioassay Linked Fractionation
Active Compound(s) Characterisation
Pure Compound, Standardised Extracts
1. Pharmacology
2. Toxicity
3. Clinical Pharmacology
Clinical Trials
Bio-availability
Registration
Commercial
Production
Marketing
Reverse pharmacology
 What is required is “Scientific evidence”
 Answer lies in providing scientific validation
for efficacy and safety
 Screening based on ethnomedical and
ethnobotanical lead as chances of hitting the
target is more
System biology
The health triangle. The survival potential of all living systems, H, is expressed in the health
triangle, structured with life’s common denominator: Intelligence, Energy and Organization.
Synergy
 Most of the effective phytomedicine in market are
as whole extracts of plants
 Practitioners believe that synergistic interactions
between the components of individual or mixture
of herbs are a vital part of therapeutic efficacy
 Mechanism of action of many phytomedicine is
still unknown and there are several instance
where total extract shows better activity than an
equalent dose of isolated compound
 chemical and pharmacological evidence to
demonstrate conclusively the concept of
synergism
Multi-target approach
 Combinations of herbs are normal and are
based on empirical observation and
reasoning based on a particular patient
 these herbal combinations may not be
targeted to a particular organ (multi-targeted),
cell, tissue or any biochemical system,
making this synergy even more difficult to
identify
 possibility of drug interactions and the
adverse reactions arising out of these have to
be checked before coming out with the drug
Multiple Targets Need A Combo
Plant A
Plant B
Plant C
Plant D
Plant E
Plant F
Plant G
Plant H
Pain,
Cartilage
Inflammation
Oxidative stress
Osteoporosis
Anabolic
CNS
Immunomodulator
Antistress
Bioavailability
Lubricant
Activity Matrix: Systems-Biology Approach
Pharmacovigilance
 Any thing herbal is safe!!?????
 Adverse drug reactions (ADR)
 Drug-drug interactions
 Herb-Drug interactions
 Toxicity of the isolated ingredients
 Traditional process (Shodhana)
Traditional Medicine: Threats
 Poor positioning on a global level
 Ignored by the global scientific community
 Very little scientific research validations
 Very little publications in peer-reviewed
science Journals
 Deliberate negative propagandas
Traditional medicine: Future
Innovative, Effective and
Aggressive use of Emerging
Technologies without
Compromising the Basic
Principles will be the main key
towards the bright future
Final Product
Global Market
Traditional Approach
Selection of potential plants


Extraction and fractionation

IPR

Drug Discovery
Activity guided isolation of active copounds

Clinical studies


Standardization of the formulation(s)


Toxicity stuides
Formulation and Doasge studies
Pharmacological studies